Burgan W - Search Results

1

Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275.

Camphausen K, Burgan W, Cerra M, Oswald KA, Trepel JB, Lee MJ, Tofilon PJ. Camphausen K, et al. Among authors: burgan w. Cancer Res. 2004 Jan 1;64(1):316-21. doi: 10.1158/0008-5472.can-03-2630. Cancer Res. 2004. PMID: 14729640

2

Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.

Russell JS, Brady K, Burgan WE, Cerra MA, Oswald KA, Camphausen K, Tofilon PJ. Russell JS, et al. Cancer Res. 2003 Nov 1;63(21):7377-83. Cancer Res. 2003. PMID: 14612536

3

Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of gammaH2AX foci.

Camphausen K, Brady KJ, Burgan WE, Cerra MA, Russell JS, Bull EE, Tofilon PJ. Camphausen K, et al. Mol Cancer Ther. 2004 Apr;3(4):409-16. Mol Cancer Ther. 2004. PMID: 15078984

4

Transcriptional signature of flavopiridol-induced tumor cell death.

Lü X, Burgan WE, Cerra MA, Chuang EY, Tsai MH, Tofilon PJ, Camphausen K. Lü X, et al. Mol Cancer Ther. 2004 Jul;3(7):861-72. Mol Cancer Ther. 2004. PMID: 15252147

5

Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid.

Camphausen K, Cerna D, Scott T, Sproull M, Burgan WE, Cerra MA, Fine H, Tofilon PJ. Camphausen K, et al. Int J Cancer. 2005 Apr 10;114(3):380-6. doi: 10.1002/ijc.20774. Int J Cancer. 2005. PMID: 15578701

6

Enhanced tumor cell radiosensitivity and abrogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin.

Bull EE, Dote H, Brady KJ, Burgan WE, Carter DJ, Cerra MA, Oswald KA, Hollingshead MG, Camphausen K, Tofilon PJ. Bull EE, et al. Clin Cancer Res. 2004 Dec 1;10(23):8077-84. doi: 10.1158/1078-0432.CCR-04-1212. Clin Cancer Res. 2004. PMID: 15585643

7

Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine.

Dote H, Cerna D, Burgan WE, Carter DJ, Cerra MA, Hollingshead MG, Camphausen K, Tofilon PJ. Dote H, et al. Clin Cancer Res. 2005 Jun 15;11(12):4571-9. doi: 10.1158/1078-0432.CCR-05-0050. Clin Cancer Res. 2005. PMID: 15958643

8

ErbB3 expression predicts tumor cell radiosensitization induced by Hsp90 inhibition.

Dote H, Cerna D, Burgan WE, Camphausen K, Tofilon PJ. Dote H, et al. Cancer Res. 2005 Aug 1;65(15):6967-75. doi: 10.1158/0008-5472.CAN-05-1304. Cancer Res. 2005. PMID: 16061682

9

In vitro and in vivo radiosensitization induced by the ribonucleotide reductase inhibitor Triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone).

Barker CA, Burgan WE, Carter DJ, Cerna D, Gius D, Hollingshead MG, Camphausen K, Tofilon PJ. Barker CA, et al. Clin Cancer Res. 2006 May 1;12(9):2912-8. doi: 10.1158/1078-0432.CCR-05-2860. Clin Cancer Res. 2006. PMID: 16675588

10

Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells.

de la Peña L, Burgan WE, Carter DJ, Hollingshead MG, Satyamitra M, Camphausen K, Tofilon PJ. de la Peña L, et al. Mol Cancer Ther. 2006 Jun;5(6):1504-10. doi: 10.1158/1535-7163.MCT-06-0091. Mol Cancer Ther. 2006. PMID: 16818509

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters